CD4 and kidney disorder: Following adoptive transfer, mice in the active treatment group had delayed progression to significant renal disease, such that eight weeks after cell transfer, only 32% of animals in the treatment group had developed proteinuria compared to 59% in the CD4+CD25− Teff mice and 62% in the PBS control group (Figure 8, p<0.025 for both comparisons.